Related references
Note: Only part of the references are listed.Influenza Vaccine in Pediatric Recipients of Hematopoietic-Cell Transplants
Jennifer E. Schuster et al.
NEW ENGLAND JOURNAL OF MEDICINE (2023)
Alternative strategies of posttransplant influenza vaccination in adult solid organ transplant recipients
Zaid Haddadin et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2021)
Vaccine Responses in Adult Hematopoietic Stem Cell Transplant Recipients: A Comprehensive Review
Michelle Janssen et al.
CANCERS (2021)
Acute Respiratory Illnesses in Children in the SARS-CoV-2 Pandemic: Prospective Multicenter Study
Zaid Haddadin et al.
PEDIATRICS (2021)
A Randomized Trial of Two 2-Dose Influenza Vaccination Strategies for Patients Following Autologous Hematopoietic Stem Cell Transplantation
Benjamin W. Teh et al.
CLINICAL INFECTIOUS DISEASES (2021)
High dose trivalent influenza vaccine compared to standard dose vaccine in patients with rheumatoid arthritis receiving TNF-alpha inhibitor therapy and healthy controls: Results of the DMID 10-0076 randomized clinical trial
Jack T. Stapleton et al.
VACCINE (2020)
Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7)
Catherine Cordonnier et al.
LANCET INFECTIOUS DISEASES (2019)
A Double-Blind, Randomized Trial of High-Dose vs Standard-Dose Influenza Vaccine in Adult Solid-Organ Transplant Recipients
Yoichiro Natori et al.
CLINICAL INFECTIOUS DISEASES (2018)
A pilot randomized trial of adjuvanted influenza vaccine in adult allogeneic hematopoietic stem cell transplant recipients
Y. Natori et al.
BONE MARROW TRANSPLANTATION (2017)
Randomized Double-Blind Study of the Safety and Immunogenicity of Standard-Dose Trivalent Inactivated Influenza Vaccine versus High-Dose Trivalent Inactivated Influenza Vaccine in Adult Hematopoietic Stem Cell Transplantation Patients
Natasha B. Halasa et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
Immunogenicity and safety of high-dose trivalent inactivated influenza vaccine compared to standard-dose vaccine in children and young adults with cancer or HIV infection
Hana Hakim et al.
VACCINE (2016)
Randomized, double-blind comparison of standard-dose vs. high-dose trivalent inactivated influenza vaccine in pediatric solid organ transplant patients
Sarah GiaQuinta et al.
PEDIATRIC TRANSPLANTATION (2015)
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
Lorry G. Rubin et al.
CLINICAL INFECTIOUS DISEASES (2014)
Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults
Carlos A. DiazGranados et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Safety of High Dose Trivalent Inactivated Influenza Vaccine in Pediatric Patients with Acute Lymphoblastic Leukemia
Meghann McManus et al.
PEDIATRIC BLOOD & CANCER (2014)
Comparable humoral response after two doses of adjuvanted influenza A/H1N1pdm2009 vaccine or natural infection in allogeneic stem cell transplant recipients
Nathalie Dhedin et al.
VACCINE (2014)
A Randomized Trial of One versus Two Doses of Influenza Vaccine after Allogeneic Transplantation
Nicole A. Karras et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Safety and immunogenicity of a quadrivalent inactivated influenza vaccine compared to licensed trivalent inactivated influenza vaccines in adults
David P. Greenberg et al.
VACCINE (2013)
Repeated vaccination is required to optimize seroprotection against H1N1 in the immunocompromised host
Hugues de Lavallade et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients
Bilal Mohty et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Serological response to influenza vaccine after hematopoetic stem cell transplantation
S. Songuel Yalcin et al.
ANNALS OF HEMATOLOGY (2010)
Share Paper
